Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
1.
Trans R Soc Trop Med Hyg ; 117(7): 505-513, 2023 07 04.
Artículo en Inglés | MEDLINE | ID: mdl-36846906

RESUMEN

BACKGROUND: Given the lack of studies on snakebite envenoming knowledge in the general population, we examined the lifetime prevalence of snakebite and knowledge of snakebite and its prevention and first aid among recent Nigerian graduates in national service. METHODS: This questionnaire-based cross-sectional study involved 351 consenting national youth corps members at a rural orientation camp in Kano, Nigeria. RESULTS: Participants' mean age was 25.3±2.4 y. There were slightly more males (50.7%). Most attended universities (77.8%) and were mainly from the southwest (24.5%) and northeast (24.5%) geopolitical regions and the Yoruba tribe (24.7%). Their lifetime prevalence of snakebite was 4%. Their mean overall knowledge score was 6.8±3.1 out of 20. Only 0.9% had adequate knowledge. Gender (male; 7.2±3.1, t=2.83, p=0.0049), tribe (Yoruba; 7.5±2.9, F=2.968, p=0.0320), region (Southwest; 7.6±3.0, F=2.5289, p=0.0289) and nearly bitten by snake (7.8 ± 2.7, t=3.60, p=0.0004) were significantly associated with a higher mean knowledge score. CONCLUSIONS: Their lifetime prevalence of snakebites is significant, while knowledge of snakebite is very inadequate. However, the national service camp activities period provides an opportunity for educational intervention needed to raise their knowledge to optimal levels that will enable them serve as better snakebite prevention agents, as they will be working in rural communities where snakebite might be prevalent.


Asunto(s)
Mordeduras de Serpientes , Animales , Adolescente , Humanos , Masculino , Adulto Joven , Adulto , Mordeduras de Serpientes/epidemiología , Mordeduras de Serpientes/prevención & control , Nigeria/epidemiología , Estudios Transversales , Prevalencia , Serpientes , Antivenenos/uso terapéutico
2.
BMJ Glob Health ; 5(7)2020 07.
Artículo en Inglés | MEDLINE | ID: mdl-32624501

RESUMEN

The Alma Ata and Astana Declarations reaffirm the importance of high-quality primary healthcare (PHC), yet the capacity to undertake PHC research-a core element of high-quality PHC-in low-income and middle-income countries (LMIC) is limited. Our aim is to explore the current risks or barriers to primary care research capacity building, identify the ongoing tensions that need to be resolved and offer some solutions, focusing on emerging contexts. This paper arose from a workshop held at the 2019 North American Primary Care Research Group Annual Meeting addressing research capacity building in LMICs. Five case studies (three from Africa, one from South-East Asia and one from South America) illustrate tensions and solutions to strengthening PHC research around the world. Research must be conducted in local contexts and be responsive to the needs of patients, populations and practitioners in the community. The case studies exemplify that research capacity can be strengthened at the micro (practice), meso (institutional) and macro (national policy and international collaboration) levels. Clinicians may lack coverage to enable research time; however, practice-based research is precisely the most relevant for PHC. Increasing research capacity requires local skills, training, investment in infrastructure, and support of local academics and PHC service providers to select, host and manage locally needed research, as well as to disseminate findings to impact local practice and policy. Reliance on funding from high-income countries may limit projects of higher priority in LMIC, and 'brain drain' may reduce available research support; however, we provide recommendations on how to deal with these tensions.


Asunto(s)
Creación de Capacidad , Países en Desarrollo , África , Humanos , Renta , Atención Primaria de Salud
3.
Am J Trop Med Hyg ; 76(6): 1019-23, 2007 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-17556604

RESUMEN

Few studies have documented the effectiveness in west Africa of intermittent preventive treatment of malaria with sulfadoxine-pyrimethamine (SP) in pregnancy. Pregnant Nigerian women were assigned to receive either SP given twice or presumptive chloroquine (CQ) treatment followed by weekly pyrimethamine (CQ + P); 250 were enrolled in each group. Of those completing follow-up, 4 (1.8%) in the SP group and 22 (9.8%) in the CQ + P groups had a febrile illness (P = 0.005). None in the SP group but 11 (4.9%) in the CQ + P group had peripheral parasitemia prior to or during delivery (P = 0.002). Two (1.2%) in the SP group and 9 (5.0%) in the CQ + P group were anemic at delivery (P = 0.04). There were six low birth weight infants in the SP group and eight in the CQ + P group (P = 0.21). Intermittent preventive treatment with SP is superior to CQ + P for prevention of malaria and anemia in pregnant women in Nigeria.


Asunto(s)
Antimaláricos/administración & dosificación , Cloroquina/administración & dosificación , Malaria Falciparum/prevención & control , Plasmodium falciparum/crecimiento & desarrollo , Complicaciones Parasitarias del Embarazo/prevención & control , Pirimetamina/administración & dosificación , Sulfadoxina/administración & dosificación , Adulto , Animales , Peso al Nacer/efectos de los fármacos , Combinación de Medicamentos , Femenino , Hematócrito , Humanos , Recién Nacido , Nigeria , Parasitemia/parasitología , Parasitemia/prevención & control , Embarazo , Complicaciones Parasitarias del Embarazo/parasitología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA